On February 5, 2013, the Securities Association of China (SAC) promulgated a public announcement that the OTC Business Implementation Plan of eight institutions, including the CMS, was approved. This signifies that the CMS has obtained the approval for carrying out OTC business.

The OTC business is the innovative business that China Securities Regulatory Commission (CSRC) stresses on in its development this year. For the OTC business, the CSRC and the SAC organized a series of discussions to hear the reports of various securities companies on innovative business. In oral defense, the CMS's defense team was led by Deng Xiaoli, CMS vice president. It passed the expert review of the SAC with excellent performance.